Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer.

PBDE cancer diabetes endocrine disruptors environment metabolism obesity

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Aug 2023
Historique:
received: 25 07 2023
revised: 17 08 2023
accepted: 19 08 2023
medline: 9 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

There is increasing evidence of the role of endocrine disruptors (EDs) derived from commonly employed compounds for manufacturing and processing in altering hormonal signaling and function. Due to their prolonged half-life and persistence, EDs can usually be found not only in industrial products but also in households and in the environment, creating the premises for long-lasting exposure. Polybrominated diphenyl ethers (PBDEs) are common EDs used in industrial products such as flame retardants, and recent studies are increasingly showing that they may interfere with both metabolic and oncogenic pathways. In this article, a multidisciplinary panel of experts of the Italian Association of Medical Diabetologists (AMD), the Italian Society of Diabetology (SID), the Italian Association of Medical Oncology (AIOM), the Italian Society of Endocrinology (SIE) and the Italian Society of Pharmacology (SIF) provides a review on the potential role of PBDEs in human health and disease, exploring both molecular and clinical aspects and focusing on metabolic and oncogenic pathways.

Identifiants

pubmed: 37686512
pii: cancers15174237
doi: 10.3390/cancers15174237
pmc: PMC10486428
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Environ Int. 2019 Feb;123:54-60
pubmed: 30496982
Horm Res Paediatr. 2016;86(4):233-239
pubmed: 27035145
Endocr Rev. 2010 Apr;31(2):139-70
pubmed: 20051527
Lancet Oncol. 2019 Jun;20(6):763-764
pubmed: 31005580
Environ Sci Pollut Res Int. 2021 Feb;28(8):10292-10301
pubmed: 33462692
Int J Toxicol. 2017 May/Jun;36(3):229-238
pubmed: 28466692
Chemosphere. 2019 Mar;218:885-894
pubmed: 30609493
Environ Toxicol Pharmacol. 2008 May;25(3):386-92
pubmed: 21783878
Environ Sci Pollut Res Int. 2023 Feb;30(8):19642-19661
pubmed: 36648715
Int J Hyg Environ Health. 2009 Mar;212(2):109-34
pubmed: 18554980
Environ Int. 2019 Jun;127:412-419
pubmed: 30954728
Toxicol Sci. 2019 Jun 1;169(2):380-398
pubmed: 30796839
Am J Epidemiol. 2011 Nov 15;174(10):1166-74
pubmed: 21984658
Environ Sci Process Impacts. 2013 Apr;15(4):702-8
pubmed: 23467608
Environ Pollut. 2022 Sep 1;308:119670
pubmed: 35752394
Life Sci. 2021 Oct 1;282:119827
pubmed: 34273373
Sci Rep. 2016 Jun 13;6:27854
pubmed: 27291303
Environ Res. 2020 Aug;187:109531
pubmed: 32454306
Environ Health Perspect. 2012 Apr;120(4):541-6
pubmed: 22472210
Biochimie. 2010 Sep;92(9):1222-6
pubmed: 20188785
Sci Total Environ. 2022 Aug 25;836:155601
pubmed: 35504395
Curr Opin Pharmacol. 2014 Dec;19:125-33
pubmed: 25306433
Environ Health. 2022 May 16;21(1):53
pubmed: 35578291
J Pediatr Endocrinol Metab. 2015 Nov 1;28(11-12):1369-72
pubmed: 26226124
Environ Sci Process Impacts. 2019 Jun 19;21(6):950-956
pubmed: 31143904
Lancet. 2012 Mar 24;379(9821):1142-54
pubmed: 22273398
J Clin Invest. 2012 Sep;122(9):3035-43
pubmed: 22945636
Sci Total Environ. 2013 Mar 1;447:133-42
pubmed: 23376525
Environ Health Perspect. 2016 Apr;124(4):420-5
pubmed: 26372669
Pharmacol Rep. 2011;63(1):189-94
pubmed: 21441628
Front Immunol. 2021 May 07;12:664534
pubmed: 34025666
Sci Total Environ. 2009 Aug 15;407(17):4831-7
pubmed: 19539352
IARC Monogr Eval Carcinog Risks Hum. 2016;107:9-500
pubmed: 29905442
Toxicology. 1994 Jan 26;86(1-2):49-61
pubmed: 8134923
Environ Res. 2011 Aug;111(6):831-7
pubmed: 21663902
Sci Rep. 2020 Oct 22;10(1):18102
pubmed: 33093533
Am J Epidemiol. 2013 Sep 1;178(5):701-13
pubmed: 23924579
Environ Health Perspect. 2013 Jul;121(7):774-83
pubmed: 23651634
Diabetes Care. 2011 Sep;34(9):1972-9
pubmed: 21816981
Environ Health Perspect. 2013 Feb;121(2):162-9
pubmed: 23221922
NPJ Aging Mech Dis. 2017 Sep 15;3:13
pubmed: 28944077
Tumori. 2015 Mar-Apr;101(2):238-45
pubmed: 25908029
Chemosphere. 2023 Feb;314:137641
pubmed: 36584828
Environ Sci Technol. 2012 Apr 17;46(8):4633-40
pubmed: 22482873
Environ Health Perspect. 2001 Mar;109 Suppl 1:49-68
pubmed: 11250805
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1755-1764
pubmed: 31387967
Int J Toxicol. 2010 May-Jun;29(3):235-46
pubmed: 20448256
Environ Pollut. 2022 May 15;301:118943
pubmed: 35150801
Int J Toxicol. 2007 Jan-Feb;26(1):13-23
pubmed: 17365142
PLoS One. 2022 Jul 19;17(7):e0271614
pubmed: 35853081
Front Public Health. 2020 Sep 24;8:553850
pubmed: 33072697
Toxicol Sci. 2006 Jul;92(1):157-73
pubmed: 16601080
Environ Health Perspect. 2001 Apr;109(4):399-407
pubmed: 11335189
Arch Toxicol. 2018 Nov;92(11):3415-3433
pubmed: 30206662
Front Genet. 2022 Aug 12;13:904607
pubmed: 36035174
Molecules. 2021 Feb 13;26(4):
pubmed: 33668501
Cancers (Basel). 2022 Jun 02;14(11):
pubmed: 35681752
Reprod Toxicol. 2011 Apr;31(3):337-43
pubmed: 21055462
Environ Int. 2017 Mar;100:132-138
pubmed: 28089583
Environ Health. 2021 Jun 30;20(1):76
pubmed: 34193151
Environ Res. 2015 Jul;140:335-44
pubmed: 25913152
BMC Cancer. 2017 Oct 25;17(1):703
pubmed: 29070034
C R Biol. 2017 Sep - Oct;340(9-10):410-413
pubmed: 29126513
Toxicol Rep. 2018 May 25;5:615-624
pubmed: 29868454
Toxicol Sci. 2018 Mar 1;162(1):212-224
pubmed: 29112739
Ecotoxicol Environ Saf. 2021 Jun 1;215:112136
pubmed: 33735605
Diabetes Care. 2008 Sep;31(9):1802-7
pubmed: 18559655
Toxicol Sci. 2004 Mar;78(1):144-55
pubmed: 14999130
Lancet Diabetes Endocrinol. 2022 Apr;10(4):264-272
pubmed: 35271818
Int J Hyg Environ Health. 2023 Jan;247:114070
pubmed: 36442457
Environ Health. 2016 May 24;15(1):60
pubmed: 27215290
Diabetes Care. 2011 Aug;34(8):1778-84
pubmed: 21700918
Food Chem Toxicol. 2022 Sep;167:113322
pubmed: 35872254
Environ Sci Technol. 2013 Oct 15;47(20):11802-9
pubmed: 24044724
Sci Total Environ. 2023 Jul 20;883:163590
pubmed: 37088389
PLoS One. 2016 May 12;11(5):e0155190
pubmed: 27171144
Toxicology. 2019 Jan 15;412:12-18
pubmed: 30468867
Environ Res. 2017 Nov;159:1-8
pubmed: 28759783
Environ Res. 2019 Sep;176:108551
pubmed: 31376650
J Chin Med Assoc. 2023 Apr 1;86(4):388-398
pubmed: 36727784
Environ Health Perspect. 2009 Aug;117(8):1210-8
pubmed: 19672399
Environ Res. 2018 Nov;167:160-168
pubmed: 30014897
EFSA J. 2021 Oct 20;19(10):e06877
pubmed: 34712366
J Hazard Mater. 2023 Jun 15;452:131234
pubmed: 36963198
Environ Health. 2020 May 20;19(1):54
pubmed: 32434563
Ann N Y Acad Sci. 2010 Nov;1212:59-77
pubmed: 21091714
Breast Cancer Res Treat. 2011 Sep;129(2):505-11
pubmed: 21468638
Environ Toxicol Pharmacol. 2017 Dec;56:29-34
pubmed: 28869857
Toxicol Sci. 2002 Mar;66(1):105-16
pubmed: 11861977
Int J Environ Res Public Health. 2022 Jun 25;19(13):
pubmed: 35805479
J Surg Res. 2022 Nov;279:77-83
pubmed: 35724546
Environ Pollut. 2021 Jan 15;269:116162
pubmed: 33303234
Toxicol Sci. 2000 Jul;56(1):95-104
pubmed: 10869457
Int J Hyg Environ Health. 2017 Apr;220(2 Pt B):364-372
pubmed: 27876543
Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):329-339
pubmed: 30822161
Carcinogenesis. 2015 Jun;36 Suppl 1:S232-53
pubmed: 26106141
Life Sci. 2023 Jun 1;322:121616
pubmed: 36958434
Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96
pubmed: 26106142
Int J Circumpolar Health. 2014 Nov 13;73(1):25760
pubmed: 25442219

Auteurs

Valerio Renzelli (V)

Italian Association of Clinical Diabetologists, 00192 Rome, Italy.

Marco Gallo (M)

Endocrinology and Metabolic Diseases Unit, AO SS Antonio e Biagio e Cesare Arrigo of Alessandria, 15121 Alessandria, Italy.

Lelio Morviducci (L)

Diabetology and Nutrition Unit, Department of Medical Specialities, ASL Roma 1, S. Spirito Hospital, 00193 Rome, Italy.

Giampiero Marino (G)

Internal Medicine Department, Ospedale dei Castelli, Asl Roma 6, 00040 Ariccia, Italy.

Alberto Ragni (A)

Endocrinology and Metabolic Diseases Unit, AO SS Antonio e Biagio e Cesare Arrigo of Alessandria, 15121 Alessandria, Italy.

Enzo Tuveri (E)

Diabetology, Endocrinology and Metabolic Diseases Service, ASL-Sulcis, 09016 Iglesias, Italy.

Antongiulio Faggiano (A)

Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

Rossella Mazzilli (R)

Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

Annalisa Natalicchio (A)

Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70121 Bari, Italy.

Maria Chiara Zatelli (MC)

Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Monica Montagnani (M)

Department of Precision and Regenerative Medicine and Ionian Area, Section of Pharmacology, University of Bari Aldo Moro, 70121 Bari, Italy.

Stefano Fogli (S)

Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Dario Giuffrida (D)

Department of Oncology, Istituto Oncologico del Mediterraneo, Viagrande, 95029 Catania, Italy.

Antonella Argentiero (A)

Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.

Romano Danesi (R)

Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Stella D'Oronzo (S)

Interdisciplinary Department of Medicine, University of Bari Aldo Moro, 70121 Bari, Italy.

Stefania Gori (S)

Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, 37024 Verona, Italy.

Tindara Franchina (T)

Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, 98122 Messina, Italy.

Antonio Russo (A)

Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90133 Palermo, Italy.

Matteo Monami (M)

Diabetology, Careggi University Hospital, University of Florence, 50134 Florence, Italy.

Laura Sciacca (L)

Department of Clinical and Experimental Medicine, Endocrinology Section, University of Catania, 95124 Catania, Italy.

Saverio Cinieri (S)

Medical Oncology Division, Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, 72100 Brindisi, Italy.

Annamaria Colao (A)

Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80138 Naples, Italy.
UNESCO Chair, Education for Health and Sustainable Development, Federico II University, 80131 Naples, Italy.

Angelo Avogaro (A)

Department of Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, 35122 Padova, Italy.

Graziano Di Cianni (G)

Diabetes Unit, Livorno Hospital, 57100 Livorno, Italy.

Francesco Giorgino (F)

Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70121 Bari, Italy.

Nicola Silvestris (N)

Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, 98122 Messina, Italy.

Classifications MeSH